SL Science Holding Limited (SLBT)
Last updated: 2026-10-24 14:21:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
SL Science Holding Limited (SLBT) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.15, with a market capitalization of $734.60M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.15 to $14.50. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$734.60M | |
$1.28 | |
$53.95 | |
$1.15 | |
$1.31 | |
30.58K | |
70.74K | |
-- | |
$14.50 | |
$1.15 | |
-- | |
-- |
SL Science Holding Limited (SLBT) Latest Closing Stock Price
SL Science Holding Limited (SLBT) last closed at $1.31 as of 2026-10-23 23:31:00, unchanged from the previous close of $1.31.
During the latest regular trading session, SLBT traded between $1.15 and $53.95, with a volume of 30.58K shares. The closing price was near the lower end and near the lower end of its 52-week range.
SL Science Holding Limited (SLBT) 7-Day Stock Price Change
Over the past seven days, SL Science Holding Limited (SLBT) moved from $1.55 to $1.15, representing a decline of 25.81% ($0.40).
The stock traded between $1.15 and $1.75 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 51.71 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
SLBT 52-Week Price Position
Position in Range: 0.0%
SLBT is currently trading at $1.15, placing it 0.0% of the way from its 52-week low of $1.15 to its 52-week high of $14.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is SL Science Holding Limited (SLBT)?
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
SL Science Holding Limited Information
| Employees | 20 |
| Exchange | NASDAQ |
| Company Website |
How to Buy SL Science Holding Limited (SLBT) Stock on MEXC
Eligible investors can buy real shares of SL Science Holding Limited (SLBT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is SL Science Holding Limited (SLBT) stock price today?
2.Is SLBT stock going up or down today?
3.What is SLBT pre-market price?
4.What is SLBT after-hours price?
5.Is SLBT stock trading now?
6.Where does SLBT sit relative to its 52-week high and low?
7.What sector is SL Science Holding Limited in?
8.What is SL Science Holding Limited's market capitalization and where is it listed?
9.How is SLBT valued in terms of P/E ratio and EPS?
10.Does SL Science Holding Limited pay a dividend?
Explore More US Stocks
Search Stocks
SLBT Stock Calculator
Estimate the value between SLBT shares and USD.
SLBT Shares to USD
1.00 SLBT shares = 1.15 USD
Calculations are estimates based on the latest available price and are for reference only.


